We serve Chemical Name:1-(4-bromophenyl)-2-methylpropan-1-one CAS:49660-93-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(4-bromophenyl)-2-methylpropan-1-one
CAS.NO:49660-93-7
Synonyms:4′-bromoisobutyrophenone;4-bromophenyl isopropyl ketone;1-bromo-4-(2-methylpropanoyl)benzene;isopropyl 4-bromophenyl ketone;1-(4-bromophenyl)-2-methyl-1-propanone
Molecular Formula:C10H11BrO
Molecular Weight:227.09800
HS Code:2914700090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:17.07000
Exact Mass:225.99900
LogP:3.28780
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4′-bromoisobutyrophenone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(4-bromophenyl)-2-methyl-1-propanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4′-bromoisobutyrophenone Use and application,isopropyl 4-bromophenyl ketone technical grade,usp/ep/jp grade.
Related News: This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. 1-(4-bromophenyl)-2-methylpropan-1-one manufacturer The European Medicines Agency did not say how many shots were affected, but Reuters has reported it involves millions of doses, making it harder for J&J to meet a target of delivering 55 million to Europe by end of June. 1-(4-bromophenyl)-2-methylpropan-1-one supplier In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells. 1-(4-bromophenyl)-2-methylpropan-1-one vendor This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. 1-(4-bromophenyl)-2-methylpropan-1-one factory Airlines operating in the United States will be required to ask all passengers booked on flights from outside the US if they��ve been to mainland China in last 14 days.
